CHOP

HealthQuest Capital Welcomes Ashley McEvoy to its Advisory Board

Retrieved on: 
Tuesday, April 9, 2024
Worldwide, Growth, CHOP, IAB, Executive, SAN, McEvoy, Hospital, Ecosystem, Johnson & Johnson, Procter & Gamble, Children's Hospital of Philadelphia, Medtech, Pharmaceutical industry

SAN FRANCISCO, April 9, 2024 /PRNewswire/ -- HealthQuest Capital, a private asset firm that provides capital to transformative healthcare companies, today announced the addition of Ashley McEvoy to its Industry Advisory Board (IAB). McEvoy brings over 20 years of experience from Johnson & Johnson. This appointment will enhance HealthQuest Capital as a value-add investor for its ecosystem of portfolio companies by adding another complementary industry leader to drive progress within the healthcare space.

Key Points: 
  • SAN FRANCISCO, April 9, 2024 /PRNewswire/ -- HealthQuest Capital , a private asset firm that provides capital to transformative healthcare companies, today announced the addition of Ashley McEvoy to its Industry Advisory Board (IAB).
  • This appointment will enhance HealthQuest Capital as a value-add investor for its ecosystem of portfolio companies by adding another complementary industry leader to drive progress within the healthcare space.
  • Ashley McEvoy is the former Executive Vice President and Worldwide Chairman of Johnson & Johnson's MedTech division, Ashley oversaw a vast organization with 60,000 global employees and revenue exceeding $30 billion.
  • "The addition of Ashley McEvoy strengthens our ability to identify and support innovative healthcare companies.

Mastery Schools, Children's Hospital of Philadelphia Announce Innovative Healthcare High School to Address Local Healthcare Workforce Shortages with Support from Bloomberg Philanthropies

Retrieved on: 
Friday, April 5, 2024
Automation, TIA, Growth, Health, CHOP, Partnership, Education, School, Knowledge, Bureau, Bloomberg L.P., Comp, Poverty, Student, Bloomberg Philanthropies, Hospital, Workforce, Dream, Children's Hospital of Philadelphia, Nursing

PHILADELPHIA, April 5, 2024 /PRNewswire/ -- Children's Hospital of Philadelphia (CHOP) and Mastery Schools announced today an unprecedented partnership to design a high school that will help prepare students for well-paying careers in healthcare and address local education and healthcare talent needs. Through this initiative from Bloomberg Philanthropies, Mastery Hardy Williams High School will be revamped to fully integrate healthcare career knowledge and job-training with a high-quality, well-rounded high school experience for students in Philadelphia, graduating students directly into high-demand healthcare jobs at CHOP with family-sustaining wages.

Key Points: 
  • Through this initiative from Bloomberg Philanthropies , Mastery Hardy Williams High School will be revamped to fully integrate healthcare career knowledge and job-training with a high-quality, well-rounded high school experience for students in Philadelphia, graduating students directly into high-demand healthcare jobs at CHOP with family-sustaining wages.
  • "By combining classroom learning with hands-on experience, these specialized health-care high schools will prepare students for careers with opportunities for growth and advancement.
  • Despite inflation, the labor market remains incredibly competitive, with shortages in every area from direct patient care to healthcare operations to administration.
  • Bloomberg Philanthropies' investment will support school start-up costs including personnel needs, classroom and lab renovations, and other work-based learning requirements.

Love for Liam Foundation to Host the Third Annual Liam Johnson Memorial Golf Outing & Benefit Dinner on May 10, 2024

Retrieved on: 
Tuesday, March 12, 2024
Research, Epilepsy, Friends, Love, Genetic testing, Memory, CHOP, Partnership, ENGIN, Genetics, Patient, Child, Volunteering, Family, Liam, Pharmaceutical industry

The Love for Liam Foundation was formed by Heather and Kyle Johnson in memory of Liam Johnson who was diagnosed with early infantile epileptic encephalopathy.

Key Points: 
  • The Love for Liam Foundation was formed by Heather and Kyle Johnson in memory of Liam Johnson who was diagnosed with early infantile epileptic encephalopathy.
  • Funding goes directly to the Epilepsy Neurogenetics Initiative (ENGIN) at the Children’s Hospital of Philadelphia (CHOP) where Liam was cared for.
  • In its inaugural year in 2022, The Liam Johnson Memorial Golf Outing & Benefit Dinner raised over $75,000 for ENGIN Research.
  • ENGIN continues to deliver the highest level of care and targeted treatment to epilepsy patients and families.”
    To learn more about the Love for Liam Foundation, visit the website and follow the LinkedIn page.

Children's Hospital of Philadelphia's Richard D. Wood Jr. Center for Fetal Diagnosis and Treatment Earns Two Press Ganey Awards

Retrieved on: 
Thursday, March 28, 2024
Surgeon, SDU, CHOP, Press Ganey Associates, Patient, Periodic function, Pinnacle, MD, Birth, Senior counsel, Hospital, Heart, Excellence, CFDT, Test management, Children's Hospital of Philadelphia, Parent, Nursing

PHILADELPHIA, March 28, 2024 /PRNewswire/ -- The Richard D. Wood Jr. Center for Fetal Diagnosis and Treatment (CFDT) at Children's Hospital of Philadelphia (CHOP) has once again received prestigious recognition from Press Ganey, a healthcare company that evaluates patient satisfaction.

Key Points: 
  • As in 2022, 2021 and 2020, the CFDT won the 2023 Pinnacle of Excellence Award®, a preeminent, competitive achievement for leading healthcare organizations.
  • Presented annually, the award applauds hospitals and health systems that consistently sustain performance year-over-year.
  • "This award underscores the team's dedication to keeping our patients and families at the forefront of every decision and treatment option."
  • The SDU is the world's first birth facility in a pediatric hospital specifically designed for healthy mothers carrying babies with known birth defects.

CHOP Researchers Find Branched Chain Amino Acid Supplementation May Aid in Concussion Recovery

Retrieved on: 
Tuesday, March 19, 2024
Online, Research, Mind, Stroke, Concussion, Assistant, CHOP, Critical Care Medicine (journal), Patient, DSM-IV codes, Journal, Anesthesiology, Leucine, Dana Foundation, Health, University, Doctor of Philosophy, MD, Human, Valine, Critical care, Adolescence, Isoleucine, Veteran, Clinical trial, BCAA, Pediatrics, Traumatic brain injury, National Institutes of Health, Hospital, Head injury, Randomized controlled trial, Safety, Ageing, HIT, Bangladesh Technical Education Board, Medicine, Children's Hospital of Philadelphia, MSCE, Dietary supplement

PHILADELPHIA, March 19, 2024 /PRNewswire/ -- In the first clinical trial of a targeted pharmacologic therapeutic for mild traumatic brain injury in pediatric patients, scientists from the Minds Matter Concussion Frontier Program at Children's Hospital of Philadelphia (CHOP) have found preliminary evidence that adolescents and young adults with concussion who take a specific formulation of branched chain amino acid (BCAA) supplements after injury experience faster symptom reduction and return to physical activity. The findings were published online by the Journal of Neurotrauma.

Key Points: 
  • The mainstay of treatment remains symptom management with temporary modification of cognitive and physical activity and over the counter medication.
  • Although active rehabilitation strategies have shown promise for improving recovery time, including aerobic, vestibular, and vision interventions, these can be time and labor intensive.
  • To date, no targeted pharmacologic intervention to improve clinical outcomes in concussion has been evaluated in humans.
  • However, prior to this study, no human studies involving adolescents and young adults have assessed the potential benefits of this formulation of BCAAs as a specific treatment to aid in concussion recovery.

Withdrawn application: Adcetris, 23/02/2024

Retrieved on: 
Wednesday, April 3, 2024
PTCL-NOS, Lymphoma, B-cell lymphoma, CHOP, Patient, PTCL, Doxorubicin, Vincristine, CHP, Cancer, Vinblastine, European Medicines Agency, CTCL, Prednisone, Lymphocyte, Agency, Clinical trial, Skin, Dacarbazine, CD30, Cyclophosphamide, Medicine

Adcetris was designated an ‘orphan medicine’ (a medicine used in rare diseases) for peripheral T cell lymphoma 21 August 2019.

Key Points: 
  • Adcetris was designated an ‘orphan medicine’ (a medicine used in rare diseases) for peripheral T cell lymphoma 21 August 2019.
  • The cytotoxic molecule then enters the cancer cells and prevents them from dividing, causing the cancer cells to die.
  • The application was withdrawn after the European Medicines Agency had evaluated the initial information from the company and had prepared questions for the company.
  • If you are in a clinical trial and need more information about your treatment, speak with your clinical trial doctor.

International Team Led by CHOP Cancer Expert Receives Multimillion Dollar Grant for Childhood Cancer Research from Cancer Grand Challenges

Retrieved on: 
Wednesday, March 6, 2024
Survivor, Oncogene, Ewing sarcoma, Doctor of Philosophy, Neoplasm, Cancer Research UK, Hospital, Neuroblastoma, Child, National Cancer Institute, Medulloblastoma, University, Therapy, KiKa, Protein, CHOP, Survival, Pediatrics, Team, Fibrolamellar hepatocellular carcinoma, Rhabdomyosarcoma, Partnership, Pharmaceutical industry

PHILADELPHIA, March 6, 2024 /PRNewswire/ -- An interdisciplinary, global team of scientists led by Yael Mossé, MD, Professor of Pediatrics in the Cancer Center at Children's Hospital of Philadelphia (CHOP), has been selected as one of five research teams from all over the world to receive funds from Cancer Grand Challenges, a funding initiative co-founded by the National Cancer Institute and Cancer Research UK. Mossé's international team will receive up to $25 million to develop transformative new therapies for previously undruggable forms of childhood cancer.

Key Points: 
  • Mossé's international team will receive up to $25 million to develop transformative new therapies for previously undruggable forms of childhood cancer.
  • Last year, 176 global teams submitted bold ideas for tackling some of the most pressing challenges in cancer research and care.
  • The National Cancer Institute and Cancer Research UK, the world's leading funders of cancer research, co-founded and launched the Cancer Grand Challenges initiative in 2020.
  • In addition to the Team KOODAC3 award, Team MATCHMAKERS, which includes Dr. Nikolaos G. Sgourakis from CHOP, also received a Cancer Grand Challenges award of up to $25 million.

The Wyss Foundation Provides $5 Million in Funding for Children's Hospital of Philadelphia's Wyss/Campbell Center for Thoracic Insufficiency Syndrome

Retrieved on: 
Thursday, February 22, 2024
VEPTR, Division, Adrenal insufficiency, Algorithm, Spinal fusion, Spine, Education, MD, Children's Hospital of Philadelphia, Physician, FDA, Quality of life, 3D, Hospital, Surgeon, Health, Wyss, TIS, Patient, CHOP, Child, Wyss Foundation, Nursing

PHILADELPHIA, Feb. 22, 2024 /PRNewswire/ -- Children's Hospital of Philadelphia (CHOP) is thrilled to announce a gift of $5 million from the Wyss Foundation to support innovations that improve the lives of patients with thoracic insufficiency syndrome (TIS). An initial gift from Hansjörg Wyss, philanthropist and chairman of the Wyss Foundation, was made to CHOP in 2019 and honored the legacy of the late Dr. Robert Campbell, a world-renowned CHOP pediatric orthopaedic surgeon. Now, additional funding has renamed and established the Wyss/Campbell Center for Thoracic Insufficiency Syndrome, one of CHOP's frontier programs, a trailblazing group of initiatives pioneering new advances in children's health. 

Key Points: 
  • Now, additional funding has renamed and established the Wyss/Campbell Center for Thoracic Insufficiency Syndrome , one of CHOP's frontier programs, a trailblazing group of initiatives pioneering new advances in children's health.
  • The $5 million gift will ensure the Center, its clinical team, researchers and patients have the resources needed to thrive by amplifying studies, tools and education.
  • The Center will be named Wyss/Campbell Center for Thoracic Insufficiency Syndrome in perpetuity.
  • The Wyss Foundation is honored to support the team working to improve the quality of life for children living with TIS," said Molly McUsic, President of the Wyss Foundation.

Press Ganey Recognizes its HX24 Executive Award Winners for Leading Industry to Improve the Human Experience in Healthcare

Retrieved on: 
Tuesday, February 6, 2024
General Health, Consulting, Health, Professional Services, Managed Care, CEN, Human, BSN, Orlando Health, Fungal infection, Hospital, Research, Nursing, MD, MHS, WOCN, Overalls, Patient, Safety, CHOP, MSN, NGHS, HX, Walt Disney, Empathy, Physician, Methodism, Patient experience, Bell, Northwell Health, Morale, RN, Cedars-Sinai Medical Center, Organization

Press Ganey , the leader in helping healthcare providers and health plans transform the Human Experience (HX), today announced eight recipients of its HX24 Award at the organization’s annual national client conference.

Key Points: 
  • Press Ganey , the leader in helping healthcare providers and health plans transform the Human Experience (HX), today announced eight recipients of its HX24 Award at the organization’s annual national client conference.
  • This executive award honors one individual who has been an influential leader in their organization and community over the course of their career.
  • HX24 HRO Foundation Award: Northeast Georgia Health System (Gainesville, GA)
    This executive award recognizes an organization who prioritizes safety, quality, and high reliability as a main pillar.
  • HX24 CXO of the Year Award: Sven Gierlinger, Chief Experience Officer, Northwell Health
    This executive award recognizes our roots in Patient Experience and the innovators who are changing PX along with us.

Children's Hospital of Philadelphia Experts Showcase Frontier Program at Arab Health Exhibition

Retrieved on: 
Monday, January 29, 2024
Health care, Patient, Artery, Research, Chiari malformation, CHOP, Vein, Health, Arab Health, Partnership, Children's Hospital of Philadelphia, Malignancy, Business, Gravity anomaly, Glomus tumor, Congress, Hospital, Lymphatic system, Pain, EHS, Vascular anomaly, Deformity, Nursing

PHILADELPHIA, Jan. 29, 2024 /PRNewswire/ -- Showcasing its longstanding partnership with the United Arab Emirates (UAE) Emirates Health Services (EHS), Children's Hospital of Philadelphia (CHOP) will exhibit thought-leading clinical research in the EHS booth at the Arab Health 2024 Exhibition and Congress , taking place this week in Dubai.

Key Points: 
  • PHILADELPHIA, Jan. 29, 2024 /PRNewswire/ -- Showcasing its longstanding partnership with the United Arab Emirates (UAE) Emirates Health Services (EHS), Children's Hospital of Philadelphia (CHOP) will exhibit thought-leading clinical research in the EHS booth at the Arab Health 2024 Exhibition and Congress , taking place this week in Dubai.
  • "CHOP has been treating patients worldwide with vascular anomalies for more than 25 years," said Dr. Denise Adams, Director of the Comprehensive Vascular Anomalies Program at Children's Hospital of Philadelphia.
  • "We are thrilled to be showcasing our multidisciplinary expertise and innovation in this field at Arab Health.
  • Arab Health 2024 marks the sixth year that EHS has invited CHOP to exhibit its pediatric innovation alongside EHS colleagues.